Open AccessPleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?
Author(s) -
Vera Bittner
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.023687
Subject(s) - kexin , pcsk9 , proprotein convertase , ezetimibe , medicine , ldl receptor , evolocumab , endocrinology , subtilisin , cholesterol , lipoprotein , pharmacology , chemistry , biochemistry , enzyme , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom